Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Intas, India issued USFDA Warning letter

Intas facility was inspected by FDA investigators Jose E Melendez, Justin A Boyd, Pratik S

Qvents Team
August 4, 2023

Warning letter (2019) / Cadila, India /

USFDA Inspection at Cadila Ahmedabad, India in April-May 2019 by Investigators Justin A Boyd, Thomas

Qvents
June 23, 2023